申请人:MCCONNELL Darryl
公开号:US20080081802A1
公开(公告)日:2008-04-03
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
6
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)的化合物
其中
R1至R6如权利要求书中所定义
,适用于治疗以细胞过度或异常增殖为特征的疾病,并且用于制备具有上述特性的药物。